Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Pediatric Blood & Cancer|October 24, 2009
Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumoursHilko Ardon, Steven De Vleeschouwer, Frank Van Calenbergh, et al.Journal of Neurosurgery|August 4, 2004
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case reportSteven De Vleeschouwer, Frank Van Calenbergh, Philippe Demaerel, et al.Fetal Diagnosis and Therapy|October 11, 2014
Prenatal diagnosis and patient preferences in patients with neural tube defects around the advent of fetal surgery in Belgium and HollandCéline Ovaere, Alex Eggink, Jute Richter, et al.BMC Medical Genetics|September 24, 2009
Pathogenesis of vestibular schwannoma in ring chromosome 22Ellen Denayer, Hilde Brems, Paul de Cock, et al.Journal of Neuro-Oncology|February 11, 2010
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot studyHilko Ardon, Stefaan Van Gool, Isabel Spencer Lopes, et al.Cancers|October 29, 2025
Reply to Taal et al. Comment on "Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306"Maria Pia Iasella, Dries Ruttens, Daphne Hompes, et al.Cancers|April 26, 2025
Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath TumourMaria Pia Iasella, Dries Ruttens, Daphne Hompes, et al.Radiology|March 10, 2012
Gliomas: diffusion kurtosis MR imaging in gradingSofie Van Cauter, Jelle Veraart, Jan Sijbers, et al.Journal of Neurosurgery|October 31, 2002
Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneityJohanna M M Gijtenbeek, Bram Jacobs, Sandra H E Sprenger, et al.Cancer Immunology, Immunotherapy : CII|April 25, 2012
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trialHilko Ardon, Stefaan W Van Gool, Tina Verschuere, et al.Pageof 8